| Sanofi-Aventis (Suisse) SA - Zaltrap 100 mg/4 ml, concentré pour solution pour perfusion | | 62676 | | 01 | | Zaltrap 100 mg/4 ml | | concentré pour solution pour perfusion | | L01XX44 | | Aflibercept | | 20.03.2013 | | |
| | Composition | | afliberceptum 100 mg, natrii dihydrogenophosphas monohydricus, dinatrii phosphas heptahydricus, natrii citras dihydricus et acidum citricum, natrii chloridum, acidum hydrochloridum ad pH, natrii hydroxidum ad pH, saccharum, polysorbatum 20, aqua ad iniectabile, q.s. ad solutionem pro 4 ml corresp. natrium 11.118 mg. | | Packungsbestandteile | | concentré pour solution pour perfusion | | | | | | | | Active Agent | Dose |
|---|
| Afliberceptum | 100mg / 4ml |
| | BAG: Active Agent | Dose |
|---|
| Afliberceptum | 100 mg |
| | | | Inactive agents |
|---|
| Acidum Citricum | | Acidum Hydrochloridum ad Ph | | Disodium Phosphate Heptahydrate | | Sodium Chloride | | Natrii Citras Dihydricus | | Sodium Dihydrogenophosphate Monohydrate | | Natrii Hydroxidum ad Ph | | Polysorbatum 20 | | Saccharum |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | Durchstechflasche(n) | 324.67 | 369.50 | A | SL | No |
|
|
